Daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma: final results from the phase 2 GEN501 and SIRIUS trials

Publication date: June 2020Source: The Lancet Haematology, Volume 7, Issue 6Author(s): Saad Z Usmani, Hareth Nahi, Torben Plesner, Brendan M Weiss, Nizar J Bahlis, Andrew Belch, Peter M Voorhees, Jacob P Laubach, Niels W C J van de Donk, Tahamtan Ahmadi, Clarissa M Uhlar, Jianping Wang, Huaibao Feng, Ming Qi, Paul G Richardson, Sagar Lonial

Source: The Lancet Haematology - May 27, 2020 Category: Hematology Source Type: research